The new imaging detection tool is based on a molecule that, after being inoculated, marks prostate cancer cells and allows them to be tracked in case of metastasis.
Authorities Alert Method Does Not Replace PSA Test May 27, 2021
FDA Approves New Method to Detect Advanced Prostate Cancer
2021-05-29T18:44:38.002Z
The new imaging detection tool is based on a molecule that, after being inoculated, marks prostate cancer cells and allows them to be tracked in case of metastasis. The authorities warn that the method does not replace the PSA test.